Navigation Links
CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Date:4/26/2012

ATLANTA, April 26, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today its results for the first quarter of 2012.  Revenues for the first quarter of 2012 increased 7 percent to a record $32.3 million compared to $30.2 million for the first quarter of 2011.Steven G. Anderson, president and chief executive officer, said, "We achieved solid financial results in the first quarter of 2012, driven by 14 percent year-over-year and 6 percent sequential sales growth in our product segment.  As a result, gross margin improved to 66 percent, demonstrating the high margin potential of our growth oriented products including BioGlue, PerClot®, and revascularization technologies.  We also made progress on our strategic initiatives to further expand the market opportunity for these products, including the significant U.S. opportunity for PerClot.  We have resubmitted our PerClot IDE application to the FDA and expect to begin enrolling our pivotal clinical trial during the third quarter, positioning the Company for potential FDA approval and launch in 2014."

Net income for the first quarter of 2012 was $1.0 million, or $0.04 per basic and fully diluted common share, compared to net income of $1.7 million, or $0.06 per basic and fully diluted common share, for the first quarter of 2011.  Net income for the first quarter of 2012 included approximately $1.7 million in litigation expenses and an increase in reserves for lawsuits.  Net income for the first quarter of 2011 included $371,000 in costs related to litigation expenses. 

Product segment revenues were $16.5 million for the first quarter of 2012, up 14 percent from $14.4 million in the first quarter of 2011.

Surgical sealant and hemostat revenues, which con
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
2. CryoLife Enhances Management Team with Promotions
3. CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
4. CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
5. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial Results
8. CryoLife Provides Update on ValveXchange®, Inc. Investment
9. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
10. CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results
11. CryoLife Makes Equity Investment in ValveXchange® Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and the Indiana ... Forum to state legislators. The new policy forum was ... Indianapolis and featured two panel ... and State Sen. Brandt Hershman . Legislators also ... & Development Center, which is under construction on its ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... with HALO device leads to 100% patient response ... ... Calif., May 20 BARRX Medical, Inc., a global,technology leader in ... which report a 100% eradication,rate for early esophageal cancer and pre-cancerous ...
... Technologies,Inc. (Amex: PTN ) announced today that ... study of PL-3994, a novel, long-acting natriuretic peptide,receptor ... The study is placebo-controlled and double-blinded, and will ... many as 35 subjects will be,included, with six ...
Cached Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3
(Date:8/31/2015)... , ... August 31, 2015 , ... ... healthcare industry, released their latest predictive use case focused on helping hospital perform ... (HVBP). Under this program, hospital payments are adjusted based on performance across four ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental ... Western University of Health Sciences to learn more about its integrated approach to ... Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a ... ” tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits ... to help India Network members make an informed decision regarding the care they ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... one-day event geared to patients and family members, medical professionals, and researchers, covering ... mesothelioma experts. The conference is a collaborative effort between the Mesothelioma Applied ...
(Date:8/31/2015)... ... 2015 , ... Coast Dental Vista is celebrating its recent grand ... 3 p.m. near Albertsons in the Foothill Center, located at 1279 E. Vista Way. ... Dr. Jay Lopp. Call (760) 208-2518 for more details or stop by on September ...
Breaking Medicine News(10 mins):Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3
... HealthDay Reporter , THURSDAY, Sept. 15 (HealthDay News) -- Those "senior ... not be a sign of more serious problems down the ... or forgetting where you placed your keys may be a fairly ... remembering what happened a few minutes ago, or getting lost in ...
... better prevent blood clots, the drugs clopidogrel or prasugrel ... the heart muscle, in addition to acetylsalicylic acid (ASA). ... Care (IQWiG) has now investigated whether, in patients whose ... the combination of prasugrel plus ASA has a higher ...
... People who drink heavily may increase their risk of dying in ... suggests. , The findings, reported in ... and Drugs , highlight one of the less-recognized dangers of downing ... Looking at coroners, records for 95 fire ...
... from breast and cervical cancer are rising in most countries, ... at younger ages, according to a new global analysis by ... University of Washington., Breast cancer cases more than doubled around ... 1980 to 1.6 million cases in 2010, a pace that ...
... -- or merely spur drug sales? Researchers at ... Research and Policy will conduct the first comprehensive study ... health care utilization data. The research is funded ... Heart, Lung, and Blood Institute. The U.S. is ...
... HealthDay Reporter , WEDNESDAY, Sept. 14 (HealthDay News) ... known as the "metabolic syndrome" could face a higher ... such factors, new research suggests. Metabolic syndrome is ... pressure, higher-than-normal insulin levels, excess body fat around the ...
Cached Medicine News:Health News:Certain 'Senior Moments' May Signal Mental Decline 2Health News:Certain 'Senior Moments' May Signal Mental Decline 3Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 2Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 3Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 4Health News:Heavy drinkers may die needlessly in house fires 2Health News:More women dying from breast and cervical cancer at a younger age in developing countries 2Health News:More women dying from breast and cervical cancer at a younger age in developing countries 3Health News:Study to examine direct-to-consumer drug ads on TV 2Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 2Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 3Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 4
... monitor elevates bedside glucose testing to a ... the quality of central laboratory testing. ... strip technology. Current glucose strips use ... system measures and corrects hematocrit interference as ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... BreatheX is a wearable CPAP (Continuous Positive ... sleep apnea. The lightweight BreatheX CPAP device ... with its built-in, rechargeable battery, and is ... no longer need to be "plugged in ...
Paraffin Block Storage System...
Medicine Products: